Although still consistent with the histopathological diagnosis of WHO grade II glioma, such tumours displaying a high proportion of PROX1-positive cells may be further advanced on the evolution to anaplastic gliomas compared with tumours with few PROX1 expressing tumour cells. This evidence concerns the gene PROX1 and central nervous system cancer.